Wenle Xia

3.5k total citations · 1 hit paper
31 papers, 2.8k citations indexed

About

Wenle Xia is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wenle Xia has authored 31 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wenle Xia's work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Wenle Xia is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Wenle Xia collaborates with scholars based in United States, China and Belgium. Wenle Xia's co-authors include Neil L. Spector, Lei-Hua Liu, Sarah Bacus, Richard Voellmy, Hong Ma, Barry R. Keith, Gary Owens, Krystal J. Alligood, David W. Rusnak and Robert J. Mullin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Wenle Xia

31 papers receiving 2.7k citations

Hit Papers

Anti-tumor activity of GW572016: a dual tyrosine kinase i... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
    2002 548 citations Wenle Xia, Robert J. Mullin et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenle Xia United States 23 1.9k 1.3k 881 461 339 31 2.8k
Teemu T. Junttila Finland 24 2.4k 1.3× 1.6k 1.2× 1.6k 1.9× 740 1.6× 311 0.9× 32 3.7k
Robert J. Mullin United States 19 1.9k 1.0× 1.2k 0.9× 729 0.8× 785 1.7× 322 0.9× 37 3.0k
Natalia Jura United States 25 1.3k 0.7× 2.1k 1.6× 711 0.8× 375 0.8× 227 0.7× 50 3.2k
Thomas Holbro Switzerland 11 1.3k 0.7× 1.3k 1.0× 672 0.8× 300 0.7× 106 0.3× 17 2.3k
Erwin R. Boghaert United States 26 1.0k 0.5× 1.2k 0.9× 513 0.6× 170 0.4× 302 0.9× 58 2.5k
Eric A. Armstrong United States 25 1.7k 0.9× 1.3k 1.0× 437 0.5× 1.1k 2.4× 164 0.5× 51 3.0k
Edward Rosfjord United States 19 1.0k 0.5× 938 0.7× 358 0.4× 383 0.8× 138 0.4× 39 1.9k
Joseph N. Contessa United States 30 1.4k 0.7× 1.6k 1.2× 518 0.6× 1.2k 2.5× 320 0.9× 86 3.4k
Marie Prewett United States 18 1.7k 0.9× 1.4k 1.1× 661 0.8× 816 1.8× 148 0.4× 34 2.9k
Ralf Brandt United States 18 2.5k 1.3× 1.9k 1.4× 632 0.7× 1.1k 2.3× 191 0.6× 27 4.0k

Countries citing papers authored by Wenle Xia

Since Specialization
Citations

This map shows the geographic impact of Wenle Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenle Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenle Xia more than expected).

Fields of papers citing papers by Wenle Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenle Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenle Xia. The network helps show where Wenle Xia may publish in the future.

Co-authorship network of co-authors of Wenle Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Wenle Xia. A scholar is included among the top collaborators of Wenle Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenle Xia. Wenle Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Bing, Wenle Xia, Wei Cai, & Jinbin Liu. (2022). Luminescent Gold Nanoparticles with Controllable Hydrophobic Interactions. Nano Letters. 22(20). 8109–8114. 20 indexed citations
2.
3.
Xia, Wenle, David M. Gooden, Lei-Hua Liu, et al.. (2014). Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis. PLoS ONE. 9(2). e88983–e88983. 27 indexed citations
4.
Xia, Wenle, Sumin Zhao, Lei-Hua Liu, et al.. (2013). An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models. Breast Cancer Research. 15(5). R85–R85. 113 indexed citations
5.
Kurokawa, Manabu, Ji‐Yeon Kim, Joseph Geradts, et al.. (2013). A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53. Science Signaling. 6(274). ra32–ra32. 54 indexed citations
6.
Ren, Xiu-Rong, Jun-Ping Wei, Gangjun Lei, et al.. (2012). Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells. Breast Cancer Research. 14(3). R89–R89. 29 indexed citations
7.
Hartman, Zachary C., Jun-Ping Wei, Takuya Osada, et al.. (2010). An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity. Clinical Cancer Research. 16(5). 1466–1477. 21 indexed citations
8.
Morse, Michael A., Jun-Ping Wei, Zachary C. Hartman, et al.. (2009). Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo. International Journal of Cancer. 126(12). 2893–2903. 19 indexed citations
9.
Spector, Neil L., Yosef Yarden, Bradley L. Smith, et al.. (2007). Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proceedings of the National Academy of Sciences. 104(25). 10607–10612. 89 indexed citations
10.
Xia, Wenle, Intisar Husain, Lei-Hua Liu, et al.. (2007). Lapatinib Antitumor Activity Is Not Dependent upon Phosphatase and Tensin Homologue Deleted on Chromosome 10 in ErbB2-Overexpressing Breast Cancers. Cancer Research. 67(3). 1170–1175. 120 indexed citations
11.
Xia, Wenle, John Bisi, Jay C. Strum, et al.. (2006). Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers. Cancer Research. 66(3). 1640–1647. 128 indexed citations
12.
Spector, Neil L., Wenle Xia, Howard A. Burris, et al.. (2005). Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(11). 2502–2512. 290 indexed citations
13.
14.
15.
Xia, Wenle, Lei-Hua Liu, Sumin Zhao, et al.. (2003). Concurrent Exposure to Heat Shock and H7 Synergizes to Trigger Breast Cancer Cell Apoptosis while Sparing Normal Cells. Breast Cancer Research and Treatment. 77(3). 233–243. 1 indexed citations
16.
Xia, Wenle, Robert J. Mullin, Barry R. Keith, et al.. (2002). Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene. 21(41). 6255–6263. 548 indexed citations breakdown →
17.
Xia, Wenle, Richard Voellmy, & Neil L. Spector. (2000). Sensitization of tumor cells to Fas killing through overexpression of heat-shock transcription factor 1. Journal of Cellular Physiology. 183(3). 425–431. 32 indexed citations
18.
Xia, Wenle, et al.. (2000). Tumor selective G 2 /M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proceedings of the National Academy of Sciences. 97(13). 7494–7499. 70 indexed citations
19.
Xia, Wenle, et al.. (1998). Transcriptional Activation of Heat Shock Factor HSF1 Probed by Phosphopeptide Analysis of Factor 32P-labeled in Vivo. Journal of Biological Chemistry. 273(15). 8749–8755. 41 indexed citations
20.
Xia, Wenle & Richard Voellmy. (1997). Hyperphosphorylation of Heat Shock Transcription Factor 1 Is Correlated with Transcriptional Competence and Slow Dissociation of Active Factor Trimers. Journal of Biological Chemistry. 272(7). 4094–4102. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teemu T. Junttila Breakdown of academic impact, for papers by Robert J. Mullin Breakdown of academic impact, for papers by Natalia Jura Breakdown of academic impact, for papers by Thomas Holbro Breakdown of academic impact, for papers by Erwin R. Boghaert Breakdown of academic impact, for papers by Eric A. Armstrong Breakdown of academic impact, for papers by Edward Rosfjord Breakdown of academic impact, for papers by Joseph N. Contessa Breakdown of academic impact, for papers by Marie Prewett Breakdown of academic impact, for papers by Ralf Brandt
Rankless by CCL
2026